Who invested in Kovina Therapeutics

One round we have observed, with the 3 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

$275Kraised across 1 round since 2022, from 1 source

Latest round: Grant, $275KNov 2022
Investors: 3

See who backed them

The rounds

Nov 2022
Grant$275K
Source recorded

Founders and team

From Kovina Therapeutics's own website and the SEC filings it signed: 1 founder, 3 on the team.

Elliot Androphy M.D.Founder/Chief Scientific Officer

Kristin ShermanCEO
Elliot AndrophyChief Scientific Officeri
Fritz FrenchChairman of the Boardi

On the board, as filediSusan MahonyTeri WilleyWilliam Ringo

Everyone who backed them

Elevate VenturesVC firm1round

National Cancer Institute (NCI)Investment firm1round

National Institute of Allergy and Infectious DiseasesInvestment firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Kovina Therapeutics as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Elevate VenturesAngel networkPer its own site

Quick answers about Kovina Therapeutics

Who invested in Kovina Therapeutics?

Kovina Therapeutics's investors include Elevate Ventures, National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases.

How much has Kovina Therapeutics raised?

Kovina Therapeutics has raised $275K across 1 round since 2022.

When did Kovina Therapeutics last raise?

Kovina Therapeutics's most recent round was a Grant of $275K in Nov 2022.

What was Kovina Therapeutics's biggest round?

Its most recent round, $275K in Nov 2022, is also its largest on record.

Who backed Kovina Therapeutics first?

Kovina Therapeutics's first round on record, in Nov 2022, was backed by Elevate Ventures, National Cancer Institute (NCI) and National Institute of Allergy and Infectious Diseases.